fluorobenzenes has been researched along with Cardiomyopathy, Congestive in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aakhus, S; Andreassen, J; Askevold, ET; Aukrust, P; Broch, K; Gjertsen, E; Godang, K; Gullestad, L; Smith, HJ; Stueflotten, W; Svendsmark, R; Ueland, T; Yndestad, A | 1 |
| Fujii, M; Horie, M; Ibe, K; Kawahara, C; Nakae, I; Sakai, H; Tsutamoto, T; Yamaji, M; Yamamoto, T | 1 |
2 trial(s) available for fluorobenzenes and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
The effect of rosuvastatin on inflammation, matrix turnover and left ventricular remodeling in dilated cardiomyopathy: a randomized, controlled trial.
Topics: Adult; Aged; Cardiomyopathy, Dilated; Cholesterol, LDL; Extracellular Matrix; Female; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Ventricular Function, Left; Ventricular Remodeling | 2014 |
Effect of atorvastatin vs. rosuvastatin on cardiac sympathetic nerve activity in non-diabetic patients with dilated cardiomyopathy.
Topics: Aged; Atorvastatin; Cardiomyopathy, Dilated; Female; Fluorobenzenes; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Pyrimidines; Pyrroles; Radionuclide Imaging; Rosuvastatin Calcium; Stroke Volume; Sulfonamides; Sympathetic Nervous System; Time Factors | 2011 |